NO931655L - Syntetiske lipid a glykokonjugatantigener for anvendelse i vaksiner - Google Patents
Syntetiske lipid a glykokonjugatantigener for anvendelse i vaksinerInfo
- Publication number
- NO931655L NO931655L NO93931655A NO931655A NO931655L NO 931655 L NO931655 L NO 931655L NO 93931655 A NO93931655 A NO 93931655A NO 931655 A NO931655 A NO 931655A NO 931655 L NO931655 L NO 931655L
- Authority
- NO
- Norway
- Prior art keywords
- synthetic lipid
- vaccine use
- glycoconjugate antigens
- antigens
- glycoconjugate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
- C07H11/04—Phosphates; Phosphites; Polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87940392A | 1992-05-07 | 1992-05-07 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO931655D0 NO931655D0 (no) | 1993-05-06 |
NO931655L true NO931655L (no) | 1993-11-08 |
NO180234B NO180234B (no) | 1996-12-02 |
NO180234C NO180234C (no) | 1997-03-12 |
Family
ID=25374087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO931655A NO180234C (no) | 1992-05-07 | 1993-05-06 | Immunogent konjugat for behandling av septisk sjokk, forbindelser samt kovalent konjugat mellom D-glukosamin-disakkarid og et bærerprotein |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0570682B1 (no) |
JP (1) | JPH0641200A (no) |
KR (1) | KR930023369A (no) |
AT (1) | ATE155790T1 (no) |
AU (1) | AU664609B2 (no) |
CA (1) | CA2095588A1 (no) |
DE (1) | DE69312391T2 (no) |
DK (1) | DK0570682T3 (no) |
ES (1) | ES2104984T3 (no) |
FI (1) | FI932053A (no) |
GR (1) | GR3024706T3 (no) |
IL (1) | IL105605A0 (no) |
NO (1) | NO180234C (no) |
SG (1) | SG47582A1 (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008214256A (ja) * | 2007-03-02 | 2008-09-18 | Yaizu Suisankagaku Industry Co Ltd | 双頭型配糖化合物の製造方法及び双頭型配糖化合物並びに該双頭型配糖化合物を含有する糖鎖認識タンパク質結合剤 |
CA2736134A1 (en) * | 2008-09-05 | 2010-03-11 | National Research Council Of Canada | Lps based vaccines |
CN114712383B (zh) * | 2016-03-30 | 2024-09-24 | 阿尤维斯研究有限公司 | 新组合物和治疗方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1187753B (it) * | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
CA2064194A1 (en) * | 1989-07-27 | 1991-01-28 | Nelson Teng | Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines |
-
1993
- 1993-03-17 AT AT93104369T patent/ATE155790T1/de active
- 1993-03-17 EP EP93104369A patent/EP0570682B1/en not_active Expired - Lifetime
- 1993-03-17 DK DK93104369.9T patent/DK0570682T3/da active
- 1993-03-17 DE DE69312391T patent/DE69312391T2/de not_active Expired - Fee Related
- 1993-03-17 SG SG1996002942A patent/SG47582A1/en unknown
- 1993-03-17 ES ES93104369T patent/ES2104984T3/es not_active Expired - Lifetime
- 1993-05-04 IL IL105605A patent/IL105605A0/xx unknown
- 1993-05-05 CA CA002095588A patent/CA2095588A1/en not_active Abandoned
- 1993-05-06 AU AU38419/93A patent/AU664609B2/en not_active Ceased
- 1993-05-06 FI FI932053A patent/FI932053A/fi not_active Application Discontinuation
- 1993-05-06 KR KR1019930007776A patent/KR930023369A/ko not_active Application Discontinuation
- 1993-05-06 NO NO931655A patent/NO180234C/no unknown
- 1993-05-06 JP JP5129939A patent/JPH0641200A/ja active Pending
-
1997
- 1997-09-11 GR GR970402350T patent/GR3024706T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3024706T3 (en) | 1997-12-31 |
JPH0641200A (ja) | 1994-02-15 |
NO931655D0 (no) | 1993-05-06 |
FI932053A (fi) | 1993-11-08 |
DE69312391T2 (de) | 1997-12-11 |
IL105605A0 (en) | 1993-09-22 |
AU664609B2 (en) | 1995-11-23 |
AU3841993A (en) | 1993-11-11 |
CA2095588A1 (en) | 1993-11-08 |
EP0570682B1 (en) | 1997-07-23 |
NO180234C (no) | 1997-03-12 |
ES2104984T3 (es) | 1997-10-16 |
EP0570682A1 (en) | 1993-11-24 |
DE69312391D1 (de) | 1997-08-28 |
DK0570682T3 (da) | 1998-02-16 |
KR930023369A (ko) | 1993-12-18 |
SG47582A1 (en) | 1998-04-17 |
NO180234B (no) | 1996-12-02 |
ATE155790T1 (de) | 1997-08-15 |
FI932053A0 (fi) | 1993-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2092306T3 (es) | Adyuvante para vacunas. | |
FR2598622B1 (fr) | Adjuvants immunologiques pour vaccins polysaccharidiques | |
NO930938D0 (no) | Forbedrede vaksiner | |
IT1205820B (it) | Adiuvante immunologico per vaccini polisaccaridici | |
ATE169825T1 (de) | Imfpstoff, enthaltend ein pneumokokkenpolysaccharid-konjugat | |
PL304419A1 (en) | Urease based vaccine against heliobacter infections | |
ATE165515T1 (de) | Immuntoleranzinduzierendes agens | |
FI862868A (fi) | Nya aminofenoler och deras anvaendning i oxiderbara haorfaergmedel. | |
DE69419966D1 (de) | Impstoff gegen Streptococcus suis-Infektion | |
ATE261314T1 (de) | P53 impfstoff | |
NL990018I1 (nl) | Vaccin tegen Pasteurella. | |
ES458197A1 (es) | Un procedimiento para la preparacion de nuevos peptidoglica-nos. | |
NO931655D0 (no) | Syntetiske lipid a glykokonjugatantigener for anvendelse i vaksiner | |
FI923348A (fi) | Laekemedel och foerfaranden foer kelandering av aids och aids-relaterade komplex (arc) med anvaendning av kolhydratantigener och antikroppar mot kolhydrater. | |
FI913475A0 (fi) | Klass ii protein med immunologiska baerar- och foerstaerkningsegenskaper fraon yttermembranen i neisseria meningitidis och vaccin innehaollande detta. | |
IL106903A0 (en) | Bacterial vaccines using vaccine strains of pathogenic bacterial | |
KR880011071A (ko) | 신규한 알킬 알카노에이트, 그의 제조방법 및 백신에 있어서 그의 에스테르의 수성 유액의 용도 | |
ATA29891A (de) | Vakzine für eine immuntherapie | |
RU93005000A (ru) | Композиция вакцин, способ ее получения, способ исключения иммунной реакции |